Pfizer begins late-stage human study on an mRNA flu shot

Drugmaker Pfizer said Wednesday it has begun a late-stage human trial of an influenza vaccine that uses the pioneering messenger-RNA deployed widely for the coronavirus.

Source: washingtontimes.com

Please follow and like us: